Sumitomo Dainippon Pharma Annual Report 2017
101/102

FTSE4Good Index SeriesExternal Evaluations of Sumitomo Dainippon Pharma Groupon SustainabilityThe FTSE4Good Index Series is created by the global index provider FTSE Russell (U.K.) to measure the performance of companies demonstrating strong Environmental, Social and Governance (ESG) practices. Sumitomo Dainippon Pharma has been independently assessed according to the FTSE4Good criteria, and has continuously satised the requirements to become a constituent of this index series since 2003.SNAM Sustainability IndexThe SNAM Sustainability index is created by the SOMPO JAPAN Nippon Asset Management (SOMPO JAPAN), and is used in SRI (socially responsible investment) fund for pension funds or institutional investors to invest widely in companies with the high ESG (environment, society, governance) evaluation ratings. Sumitomo Dainippon Pharma was selected to this index as of June 2017.The FTSE Blossom Japan Index is created by the global index provider FTSE Russell (U.K.) to measure the performance of Japanese companies demonstrating strong Environmental, Social and Governance (ESG) practices. Sumitomo Dainippon Pharma has been independently assessed according to the FTSE Blossom Japan Index criteria, and has satisfied the requirements to become a constituent of this index as of June 2017.The MSCI Global Sustainability Indexes is a globally renowned SRI (Socially Responsible Investment) index generated MSCI Inc. of the U.S. Sumitomo Dainippon Pharma has been independently assessed according to the MSCI Global Sustainability Indexes criteria, and has continuously satisfied the requirements to become a constituent of these indexes since 2010.The MSCI Japan ESG Select Leaders Index targets 50% of the free float-adjusted market capitalization of each Global Industry Classification Standard (GICS®) Sector and is designed to target companies that have high Environmental, Social and Governance (ESG) performance. Sumitomo Dainippon Pharma has been independently assessed according to the MSCI Japan ESG Select Leaders Index criteria, and has satisfied the requirements to become a constituent of this index as of June 2017.FTSE Blossom Japan IndexMSCI Global Sustainability IndexesMSCI Japan ESG Select Leaders IndexThe MSCI Japan Empowering Women Index (WIN) aims to represent the performance of companies that are leading within their GICS® sector groups in terms of promoting and maintaining gender diversity while also meeting certain quality factor criteria. Sumitomo Dainippon Pharma has been independently assessed according to the MSCI Japan Empowering Women Index (WIN) criteria, and has satisfied the requirements to become a constituent of this index as of June 2017.MS-SRI is a socially responsible investment stock index of 150 companies selected from about 4,000 listed Japanese companies by Morningstar based on their social quality. Sumitomo Dainippon Pharma was selected to the index as of January 2017.MSCI Japan Empowering Women Index (WIN)Morningstar Socially Responsible Investment IndexSumitomo Dainippon Pharma Co., Ltd. Annual Report 2017100

元のページ  ../index.html#101

このブックを見る